Organisation paid for research Program year 2025 Source: CMS Open Payments

Mobile Heart Specialists

Neither a doctor nor a teaching hospital

Research payments

$425,410

29 payments

Through program year 2025, Mobile Heart Specialists is reported as receiving $425,410 in research payments, across 29 payments.

By program year

6 rows

Year	Kind	Amount	Payments
2025	Research	$126,229	1
2024	Research	$133,766	1
2022	Research	$65	1
2021	Research	$13,811	4
2020	Research	$36,004	3
2019	Research	$115,535	19

Breakdown

Who paid Research payments · program years 2019–2025

Novartis Pharmaceuticals Corporation $260,109 3 payments
Boehringer Ingelheim Pharmaceuticals, Inc. $130,093 6 payments
Boehringer Ingelheim Pharma GmbH & Co.KG $16,774 5 payments
Bayer HealthCare Pharmaceuticals Inc. $13,575 3 payments
Boehringer Ingelheim International GmbH $4,003 3 payments
Boehringer Ingelheim Canada Ltd.Ltee $503 5 payments
Boehringer Ingelheim France S.A.S. $355 4 payments

Studies the money was for Research payments · program years 2019–2025

Hps-4/Timi 65/Orion-4: A Double-Blind Randomized Placebo-Controlled Trial Assessing the Effects of Inclisiran on Clinical Outcomes Among People With Atherosclerotic Cardiovascular Disease $260,109 3 payments
Exercise capacity study in HFrEF $70,851 7 payments
Exercise capacity study in HFpEF $67,114 12 payments
Empagliflozin for prevention of HHF and death after an AMI $13,697 3 payments
BAY59-7939 prevention of CV events in vascular disease $13,575 3 payments
Empagliflozin for prevention of HHF and death afte $65 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.